Recipharm Reports - Industry Research
Reports Featuring Recipharm
Healthcare CDMO Market
The healthcare contract development and manufacturing organization (CDMO) market was valued at USD 273.21 billion in the current year and is expected to reach USD 432.03 million by the end of the forecast period, registering a CAGR of 8.02%.
Cell And Gene Therapy Contract Development And Manufacturing Organization Market
The Cell And Gene Therapy Contract Development And Manufacturing Organization Market size is estimated at USD 3.18 billion in 2024, and is expected to reach USD 6.90 billion by 2028, growing at a CAGR of 16.73% during the forecast period (2024-2028).
_Market_Major_Players_Logo.webp){kind=logo}
Pharmaceutical CMO Market
The Pharmaceutical CMO Market size is estimated at USD 171.18 billion in 2024, and is expected to reach USD 230.38 billion by 2029, growing at a CAGR of 6.12% during the forecast period (2024-2029).
Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
The Pharmaceutical Contract Development and Manufacturing Organization Market size is estimated at USD 238.47 billion in 2024, and is expected to reach USD 330.36 billion by 2029, growing at a CAGR of 6.74% during the forecast period (2024-2029).
Europe Pharmaceutical Contract Manufacturing Market
Europe Pharmaceutical Contract Manufacturing Market is expected to grow at a CAGR of 5.71% in the forecast period.
Antibody Drug Conjugates Contract Manufacturing Market
The antibody-drug conjugates contract manufacturing market is projected to register a CAGR of 12.5% during the forecast period.
Global Active Pharmaceutical Ingredients CDMO Market
The Global Active Pharmaceutical Ingredients CDMO Market size is estimated at USD 118.09 billion in 2024, and is expected to reach USD 178.47 billion by 2029, growing at a CAGR of 8.61% during the forecast period (2024-2029).
Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market
The Asia-Pacific Pharmaceutical Contract Manufacturing Organization Market size is estimated at USD 55.15 billion in 2024, and is expected to reach USD 83.85 billion by 2029, growing at a CAGR of 8.74% during the forecast period (2024-2029).
NA Pharmaceutical CMO Market
The North America Pharmaceutical Contract Manufacturing Market was valued at USD 45.13 billion is expected to reach USD 62.04 billion at a CAGR of 5.2% over the forecast period from 2021 - 2026.
